Drug information for DIPENTUM
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
250MG
Prescription
(Reference Drug)
OLSALAZINE SODIUM
olsalazine
MEDA PHARMS
19715
2009-11-12 Letter
2009-08-13 Label
2007-07-16 Letter
2002-08-09 Letter
2002-01-18 Letter
Drug Adverse Effects information for DIPENTUM
Role code
Indications
Reaction
# Reports
SS
COLITIS ULCERATIVE
DIALYSIS
1
SS
COLITIS ULCERATIVE
NEPHROCALCINOSIS
1
SS
COLITIS ULCERATIVE
PRODUCT QUALITY ISSUE
1
SS
COLONOSCOPY
DIALYSIS
1
SS
COLONOSCOPY
NEPHROCALCINOSIS
1
SS
COLONOSCOPY
PRODUCT QUALITY ISSUE
1
C
MULTIPLE SCLEROSIS
BRADYPHRENIA
1
C
MULTIPLE SCLEROSIS
FALL
1
C
MULTIPLE SCLEROSIS
FATIGUE
1
C
MULTIPLE SCLEROSIS
INFLUENZA LIKE ILLNESS
1
C
MULTIPLE SCLEROSIS
INJECTION SITE HYPERSENSITIVITY
1
C
MULTIPLE SCLEROSIS
NAUSEA
1
C
MULTIPLE SCLEROSIS
PYREXIA
1
C
MULTIPLE SCLEROSIS
SARCOMA UTERUS
1
C
URINARY TRACT INFECTION
BRADYPHRENIA
1
C
URINARY TRACT INFECTION
FALL
1
C
URINARY TRACT INFECTION
FATIGUE
1
C
URINARY TRACT INFECTION
INFLUENZA LIKE ILLNESS
1
C
URINARY TRACT INFECTION
INJECTION SITE HYPERSENSITIVITY
1
C
URINARY TRACT INFECTION
NAUSEA
1
C
URINARY TRACT INFECTION
PYREXIA
1
C
URINARY TRACT INFECTION
SARCOMA UTERUS
1
Ads by Google